Christopher Brett Primiano Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Brett Primiano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Brett Primiano. Christopher Brett Primiano is EVP, CBO, GC & Secretary in Karyopharm Therapeutics Inc. ($KPTI) and SVP, OPS, BUS DEV, GC & SEC in Karyopharm Therapeutics Inc. ($KPTI) and SVP,CORP DEV,GEN COUNSEL&SEC. in Karyopharm Therapeutics Inc. ($KPTI).
Latest Insider Trading Transactions of Christopher Brett Primiano
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 58,937 | 612,355 | 16,842 | |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.45 | 78,124 | 816,396 | 46,876 | |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.35 | 58,937 | 1,022,557 | 4,523 | 63.5 K to 4.5 K (-92.87 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 58,937 | 612,355 | 63,460 | 4.5 K to 63.5 K (+1,303.05 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.66 | 78,124 | 1,379,670 | 4,523 | 82.6 K to 4.5 K (-94.53 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.45 | 78,124 | 816,396 | 82,647 | 4.5 K to 82.6 K (+1,727.26 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 14.92 | 772 | 11,518 | 4,523 | 5.3 K to 4.5 K (-14.58 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 721 | 7,491 | 75,779 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 9.21 | 38,550 | 355,046 | 64,250 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.20 | 721 | 12,401 | 4,649 | 5.4 K to 4.6 K (-13.43 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 721 | 7,491 | 5,370 | 4.6 K to 5.4 K (+15.51 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.85 | 38,550 | 649,568 | 4,649 | 43.2 K to 4.6 K (-89.24 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 9.21 | 38,550 | 355,046 | 43,199 | 4.6 K to 43.2 K (+829.21 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 721 | 7,491 | 75,779 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 9.21 | 38,550 | 355,046 | 64,250 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.20 | 721 | 12,401 | 4,649 | 5.4 K to 4.6 K (-13.43 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 721 | 7,491 | 5,370 | 4.6 K to 5.4 K (+15.51 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.85 | 38,550 | 649,568 | 4,649 | 43.2 K to 4.6 K (-89.24 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 9.21 | 38,550 | 355,046 | 43,199 | 4.6 K to 43.2 K (+829.21 %) |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 10,054 | 65,753 | 0 | |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 14.98 | 10,054 | 150,609 | 4,649 | 14.7 K to 4.6 K (-68.38 %) |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 10,054 | 65,753 | 14,703 | 4.6 K to 14.7 K (+216.26 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 2,946 | 19,267 | 10,054 | |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 20.00 | 2,946 | 58,920 | 4,649 | 7.6 K to 4.6 K (-38.79 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 2,946 | 19,267 | 7,595 | 4.6 K to 7.6 K (+63.37 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 19.62 | 6,714 | 131,707 | 4,649 | 11.4 K to 4.6 K (-59.09 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 26,500 | 275,335 | 76,500 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 24.00 | 9,000 | 216,029 | 10,367 | 19.4 K to 10.4 K (-46.47 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 28.00 | 10,000 | 280,000 | 19,367 | 29.4 K to 19.4 K (-34.05 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 23.50 | 7,500 | 176,250 | 29,367 | 36.9 K to 29.4 K (-20.34 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 26,500 | 275,335 | 36,867 | 10.4 K to 36.9 K (+255.62 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.48 | 2,961 | 48,803 | 10,367 | 13.3 K to 10.4 K (-22.22 %) |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 0.00 | 30,300 | 0 | 30,300 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 18.00 | 81,200 | 1,461,600 | 81,200 | |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 103,000 | |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 20.00 | 5,000 | 100,000 | 3,653 | 8.7 K to 3.7 K (-57.78 %) |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 8,653 | 3.7 K to 8.7 K (+136.87 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 108,000 | |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 5,000 | 32,700 | 13,000 | |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.46 | 3,000 | 52,368 | 3,653 | 6.7 K to 3.7 K (-45.09 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.45 | 5,000 | 87,256 | 6,653 | 11.7 K to 6.7 K (-42.91 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.46 | 5,000 | 87,284 | 11,653 | 16.7 K to 11.7 K (-30.02 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 16,653 | 11.7 K to 16.7 K (+42.91 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 5,000 | 32,700 | 11,653 | 6.7 K to 11.7 K (+75.15 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 113,000 | |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 5,000 | 32,700 | 18,000 | |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 18.90 | 10,000 | 189,046 | 2,881 | 12.9 K to 2.9 K (-77.63 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 12,881 | 7.9 K to 12.9 K (+63.44 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 5,000 | 32,700 | 7,881 | 2.9 K to 7.9 K (+173.55 %) |
| May 10 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 18.01 | 2,000 | 36,024 | 2,881 | 4.9 K to 2.9 K (-40.98 %) |
| Mar 06 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.03 | 2,500 | 40,076 | 4,881 | 7.4 K to 4.9 K (-33.87 %) |
| Feb 20 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 15.01 | 1,486 | 22,298 | 7,381 | 8.9 K to 7.4 K (-16.76 %) |
| Feb 20 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 15.02 | 1,014 | 15,229 | 8,867 | 9.9 K to 8.9 K (-10.26 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 13.00 | 1,500 | 19,500 | 9,881 | 11.4 K to 9.9 K (-13.18 %) |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 10.45 | 125,000 | 1,306,250 | 125,000 | |
| Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | M | 6.54 | 17,000 | 111,180 | 23,000 | |
| Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 9.59 | 644 | 6,173 | 11,381 | 12 K to 11.4 K (-5.36 %) |
| Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 9.93 | 16,356 | 162,443 | 12,025 | 28.4 K to 12 K (-57.63 %) |
| Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Buy | M | 6.54 | 17,000 | 111,180 | 28,381 | 11.4 K to 28.4 K (+149.37 %) |
| Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.88 | 10,042 | 109,256 | 11,381 | 21.4 K to 11.4 K (-46.87 %) |
| Nov 09 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 11.25 | 4,958 | 55,755 | 21,423 | 26.4 K to 21.4 K (-18.79 %) |
| Nov 06 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Nov 06 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Buy | M | 0.00 | 15,000 | 0 | 26,381 | 11.4 K to 26.4 K (+131.80 %) |
| Oct 04 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 12.00 | 1,500 | 18,000 | 11,381 | 12.9 K to 11.4 K (-11.65 %) |
| Sep 18 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 11.00 | 2,000 | 22,000 | 12,881 | 14.9 K to 12.9 K (-13.44 %) |
| Sep 01 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.03 | 805 | 8,071 | 14,881 | 15.7 K to 14.9 K (-5.13 %) |
| Aug 30 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.00 | 2,195 | 21,950 | 15,686 | 17.9 K to 15.7 K (-12.28 %) |
| Jan 24 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | A | 10.39 | 118,000 | 1,226,020 | 118,000 | |
| Nov 14 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Sell | S | 8.19 | 4,342 | 35,544 | 15,819 | 20.2 K to 15.8 K (-21.54 %) |
| Nov 08 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | M | 0.00 | 15,000 | 0 | 15,000 | |
| Nov 08 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Buy | M | 0.00 | 15,000 | 0 | 20,161 | 5.2 K to 20.2 K (+290.64 %) |
| Jan 20 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 6.54 | 40,000 | 261,600 | 40,000 | |
| Nov 09 2015 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Sep 21 2015 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 14.94 | 75,000 | 1,120,500 | 75,000 |
Page: 1